World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
29354
World Ranking
1664
National Ranking
46

Jacques Fellay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jacques Fellay sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 442 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jacques Fellay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jacques Fellay sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 79 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jacques Fellay is affiliated with the École Polytechnique Fédérale de Lausanne in Switzerland. Their research spans multiple fields centered on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology, with particular attention to infectious diseases, immunology, epidemiology, molecular biology, and genetics.

The scientist has contributed extensively to topics related to HIV research and treatment, HIV/AIDS research and interventions, and HIV-related health complications and treatments. Additional areas of focus include immune cell function and interaction, HIV/AIDS drug development and treatment, respiratory viral infections research, and genetic associations and epidemiology.

Fellay's recent scholarly output highlights a variety of studies concerning infectious diseases and immune responses, particularly in the context of COVID-19. Noteworthy publications include:

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 (2020, Science)
  • COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation (2020, Swiss Medical Weekly)
  • Human genetic and immunological determinants of critical COVID-19 pneumonia (2022, Nature)
  • A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection (2020, Cell)
  • Truly privacy-preserving federated analytics for precision medicine with multiparty homomorphic encryption (2021, Nature Communications)

Frequent collaborators in their research include Huldrych F. Günthard, Enos Bernasconi, Roger D. Kouyos, Matthias Cavassini, and Alexandra Calmy. These co-authors have worked with Fellay on numerous studies, reflecting longstanding research partnerships.

Their work has been published repeatedly in several scholarly venues, with a significant presence in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • Zenodo (CERN European Organization for Nuclear Research)
  • The Journal of Experimental Medicine

Jacques Fellay's research contributions align with ongoing efforts to understand infectious diseases and immune mechanisms at genetic and molecular levels, underlining intersections between pathogen biology and host immune responses. Their studies often address critical public health questions pertaining to viral infections, immunity, and epidemiological strategies.

Best Publications

  • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

    Dongliang Ge;Jacques Fellay;Alexander J. Thompson;Jason S. Simon

  • Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

    Qian Zhang;Paul Bastard;Paul Bastard;Zhiyong Liu;Jérémie Le Pen

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

    Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo

  • Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

    Alexander J. Thompson;Andrew J. Muir;Andrew J. Muir;Mark S. Sulkowski;Dongliang Ge

  • Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

    Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Human genetic and immunological determinants of critical COVID-19 pneumonia

    Unknown

  • ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

    Jacques Fellay;Alexander J. Thompson;Dongliang Ge;Curtis E. Gumbs

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Common genetic variation and the control of HIV-1 in humans.

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

  • Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

    Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer

  • IL28B genotype is associated with differential expression of intrahepatic interferon‐stimulated genes in patients with chronic hepatitis C

    Thomas J. Urban;Alexander J. Thompson;Shelton S. Bradrick;Jacques Fellay

  • Influence of HLA-C Expression Level on HIV Control

    Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen

  • Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection

    Chantal Csajka;Catia Marzolini;Karin Fattinger;Laurent A. Décosterd

  • HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C

    Rasmi Thomas;Richard Apps;Ying Qi;Xiaojiang Gao

  • Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors.

    Etienne Patin;Milena Hasan;Jacob Bergstedt;Vincent Rouilly

  • A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection.

    Jean-Laurent Casanova;Helen C. Su;Covid Human Genetic Effort

  • Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges

    Barbara Piasecka;Darragh Duffy;Alejandra Urrutia;Alejandra Urrutia;Helene Quach

  • Variants in the ITPA Gene Protect Against Ribavirin-Induced Hemolytic Anemia and Decrease the Need for Ribavirin Dose Reduction

    Alexander J. Thompson;Jacques Fellay;Keyur Patel;Keyur Patel;Hans L. Tillmann;Hans L. Tillmann

  • Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque

    Margalida Rotger;Judith Dalmau;Andri Rauch;Paul McLaren

  • Evidence of dysregulation of dendritic cells in primary HIV infection.

    Rachel Lubong Sabado;Rachel Lubong Sabado;Meagan O'Brien;Meagan O'Brien;Abhignya Subedi;Abhignya Subedi;Li Qin;Li Qin

  • Common Genetic Variation and the Control of HIV-1 in Humans

    Jacques Fellay;Dongliang Ge;Kevin V. Shianna;Sara Colombo

Frequent Co-Authors

Amalio Telenti
Amalio Telenti VIR Biotechnology (United States)
David Goldstein
David Goldstein University of New South Wales
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Mary Carrington
Mary Carrington Ragon Institute of MGH, MIT and Harvard
Kevin V. Shianna
Kevin V. Shianna Duke University
Andri Rauch
Andri Rauch University of Bern
Matthias Cavassini
Matthias Cavassini University of Lausanne
Manuel Battegay
Manuel Battegay University Hospital of Basel
Dongliang Ge
Dongliang Ge Apostle Diagnostics

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to various interdisciplinary career options, especially in healthcare and research. Many professionals in this field complement their Immunology background with advanced nursing degrees to enhance patient care in immunological disorders. For those interested in nursing, exploring the cheapest pmhnp programs can be a cost-effective way to specialize in psychiatric and mental health while integrating immunological insights.

Nurse practitioners with a Doctor of Nursing Practice degree can expect competitive compensation, as reflected in the dnp salary variations nationwide. This makes further education a valuable investment for Immunology professionals aiming to advance their clinical expertise.

For nurses looking to expand their scope, bridge options like the fnp to acute care np bridge program provide a seamless transition to acute care, enabling practitioners to work with immunocompromised patients in critical settings.

Additionally, accelerated routes through accelerated np programs offer a fast track to nursing practice, appealing to Immunology graduates seeking rapid entry into clinical roles. These pathways collectively highlight the dynamic nexus between Immunology education and advanced nursing careers.

Best Scientists Citing Jacques Fellay

Trending Scientists

Recently Published Articles